{"disease":{"id":"cavernous-angioma","name":"cavernous angioma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04467489","title":"Biomarkers of CASH","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1040,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT04076449","title":"Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"yuanli Zhao","has_results":false},{"nct_id":"NCT03652181","title":"CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness","phase":"","overall_status":"COMPLETED","enrollment_count":123,"lead_sponsor_name":"University of Chicago","has_results":true},{"nct_id":"NCT04181086","title":"Pattern and Management of Intracranial Cavernoma","phase":"","overall_status":"UNKNOWN","enrollment_count":35,"lead_sponsor_name":"Assiut University","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}